Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study
Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention
Event:
ESC Congress 2017
Topic:
Antiarrhythmic drugs
Session:
Drug treatment in patients with arrhythmia
Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study
Event:
ESC Congress 2016
Topic:
Thrombosis and coagulation
Session:
Antithrombotics in daily clinical practice